Some of our cancer centers are experiencing issues.  View More Important Notifications x
texas oncology more breakthroughs. more victories



John E. Pippen, M.D., FACP

John E. Pippen, M.D., FACP

Provider Type: Physician

  • Hematology
  • Medical Oncology
Board Certifications:
  • Medical Oncology
  • Internal Medicine

General Summary


Dr. Pippen received an M.D. in 1982 from the University of Texas Southwestern Medical School in Dallas. At Baylor University Medical Center, Dallas, Texas, Dr. Pippen completed an internal medicine internship and residency from 1982 to 1985, and a medical oncology fellowship from 1993 to 1995. He received a B.S. in Zoology in 1977 from Texas A&M University, College Station.

Medical Practice

Research Interest

John E. Pippen, M.D. is interested in clinical research trials involving the prevention and treatment of breast cancer. Dr. Pippen now takes care of a large number of patients with breast cancer as well as other solid tumors, and is actively involved in clinical trials with The US Oncology Network.

Surgery Locations

Other Information

Attending Physician and Chair of the Breast Tumor Site Committee, Baylor Sammons Cancer Center, Dallas Texas

Accolades & Memberships

Internal medicine practice, Baylor University Medical Center, 1985-1993; attending physician, Baylor Medical Center, 1985-2003. Fellow, American College of Physicians; Member of Career Development Committee, American Society of Clinical Oncology; principal investigator for Faslodex clinical trial that led to FDA approval; faculty member at the 2003 American Society Clinical Oncology meeting, Chicago, IL. In addition to being an active member of multiple societies, Dr. Pippen is currently Past-Chair of the Career Development Subcommittee of the American Society of Clinical Oncology, and Chair-Elect of the Maintenance of Certification Subcommittee. Dr. Pippen has previously served on the Cancer Education Committee of ASCO.

Community Service




  • Iniparib plus Chemotherapy n Metastatic Triple-Negative Breast Cancer

    New England Journal of Medicine, 2011

  • Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: a report of a tamoxifen exemestane adjuvant multicenter trial substudy.

    Journal of Clinical Oncology, 2007

  • Determination of oestrogen-receptor status and erb b2 status of breast carcinoma: a gene expression profiling study.

    The Lancet, 2007

  • Maintenance of certification: my perspective.

    Journal of Oncology Practice, 2007

  • Phase II study of weekly albumin bound paclitaxel for patients with breast cancer heavily pretreated with taxanes.

    Clinical Breast Cancer , 2007

Show all Publications
  • Time to response: comparison of fulvestrant and oral endocrine agents.

    Clinical Breast Cancer, 2006